Educational content only. Medication mentions do not indicate availability through Vea. This article is not medical advice.
Yes, blood pressure is a recognized concern
In February 2025, the FDA required blood-pressure warnings for testosterone products following ambulatory monitoring studies. The agency also updated cardiovascular labeling after reviewing the TRAVERSE trial. Removing an earlier boxed-warning statement about cardiovascular outcomes did not mean testosterone became risk-free.
Two findings should not be confused
A study’s findings about major cardiovascular events are different from findings about blood-pressure changes. Both can matter in an individual treatment decision. Avoid treating a headline about one outcome as reassurance about every other potential adverse effect.
Discuss monitoring with the prescribing clinician
If you already take testosterone, ask how your blood pressure will be checked and what readings or symptoms should prompt contact. Bring your medication list and any home blood-pressure records. Do not change your dose, add medication, or arrange blood donation as a self-directed response to an abnormal reading.
What to bring to a follow-up
Record the date and circumstances of readings, any symptoms, and recent medication changes. Ask whether your home monitor and measurement technique are appropriate. Your clinician can decide whether a change in treatment or further evaluation is needed.
When symptoms need urgent help
Chest pain, severe shortness of breath, fainting, or sudden weakness or trouble speaking require urgent medical assessment. Do not wait for a routine hormone follow-up to address those symptoms.
About this article
Vea does not currently offer testosterone therapy. This article explains a medication safety issue and does not provide a dosing or treatment plan.